The Inhalation CDMO Market Size was valued at USD 7.9 Bn in 2023 and is predicted to reach USD 11.8 Bn by 2031 at a 5.2% CAGR during the forecast period for 2024-2031. Inhalation CDMO refers to the organization that is responsible for the development and manufacturing of inhalation contracts. For the research and production of inhalation medicinal products, these specialized service providers offer solutions that cover the entire continuum. On...
Report ID: 2708 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 178
RNAi Therapeutics and Technology Market Size is valued at USD 1.6 Bn in 2023 and is predicted to reach USD 5.28 Bn by the year 2031 at a 16.0% CAGR during the forecast period for 2024-2031. RNA interference (RNAi) therapeutics and technology represent a cutting-edge approach to disease treatment, utilizing the cell's natural regulatory mechanism to silence specific genes implicated in various disorders. At the core of RNAi...
Report ID: 2508 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 179
Chemotherapy-Induced Anemia Market Size was valued at USD 2.4 Bn in 2023 and is predicted to reach USD 3.9 Bn by 2031 at a 6.5% CAGR during the forecast period for 2024-2031. Chemotherapy induces anemia, a disorder characterized by decreased hemoglobin and red blood cells. This disease originates from the fast cell division that chemotherapy treatments frequently target. The market is being propelled primarily by the increasing recognition of ...
Report ID: 2511 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
The Bacterial Diagnostics in Aquaculture Market Size is valued at USD 3.76 Bn in 2022 and is predicted to reach USD 6.46 Bn by the year 2031 at a 6.4% CAGR during the forecast period for 2023-2031. Finding and quantifying bacterial pathogens in aquatic systems is known as bacterial diagnostics in aquaculture. Bacterial diagnostics in aquaculture is a crucial aspect of managing and maintaining the health of aquatic organisms, particularly in fi...
Report ID: 2056 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Drug Formulary Management Market Size is predicted to grow at a 5.9% CAGR during the forecast period for 2024-2031. Drug formulary management is a system used in healthcare to ensure that patients are prescribed the safest, most effective, and most affordable medications. It's essentially a list of approved medications that a healthcare organization, like a hospital or insurance plan, recommends for use by doctors. This list is based on scient...
Report ID: 2532 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Oligonucleotide Therapy Market Size is valued at USD 5.21 billion in 2023 and is predicted to reach USD 19.92 billion by the year 2031 at a 18.6% CAGR during the forecast period for 2024-2031. Oligonucleotides are some of the most promising therapeutic mechanisms for a range of hard-to-treat diseases, in particular those caused by genetic mutations. These are Short sequences of artificially created DNA or RNA molecules that attach to matching ...
Report ID: 2566 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
The Psychiatric Digital Biomarkers Market Size is valued at USD 513.3 Mn in 2023 and is predicted to reach USD 2,879.7 Mn by the year 2031 at an 24.7% CAGR during the forecast period for 2024-2031. The global market for psychiatric digital biomarkers focuses on the creation, application, and utilization of digital technologies designed to measure and analyze physiological and behavioral data for diagnosing, tracking, and treating mental i...
Report ID: 2637 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 170
The Fragment-Based Drug Discovery Market is expected to grow at a 11.0 % CAGR during the forecast period for 2023-2031. Fragment-based Drug Discovery is being used to find similar compounds like lead in drug discovery process, which is based on identification of chemical fragments, this chemical fragment may be biological target or on combining them produce a lead molecule. Increasing novel complex medical problems creating the demand for new...
Report ID: 1175 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Global Age-related Macular Degeneration (AMD) Drugs Market Size is valued at USD 9.58 Bn in 2023 and is predicted to reach USD 19.77 Bn by the year 2031 at an 9.7% CAGR during the forecast period for 2024 to 2031. Age-related Macular Degeneration (AMD) Drugs Market Size, Share & Trends Analysis Distribution by Products (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre, Other Products), Molecules (Ranibizumab, Aflibercept, Faricimab, Pegcetop...
Report ID: 2854 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 172
Weight Loss Drugs Market Size is valued at USD 26.3 billion in 2023 and is predicted to reach USD 108.9 billion by the year 2031 at a 19.7% CAGR during the forecast period for 2024-2031. The weight loss drugs market is witnessing significant growth due to the global rise in obesity rates and related health concerns. With awareness of the health risks especially associated with obesity, there's a growing demand for effective weight management s...
Report ID: 2526 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Pharmaceuticals